Related references
Note: Only part of the references are listed.18F-FDG PET/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off
Johannes Salamon et al.
EUROPEAN RADIOLOGY (2014)
Comparison of PET-CT and magnetic resonance diffusion weighted imaging with body suppression (DWIBS) for initial staging of malignant lymphomas
Velasco Stephane et al.
EUROPEAN JOURNAL OF RADIOLOGY (2013)
Standardized uptake values for [18F] FDG in normal organ tissues: Comparison of whole-body PET/CT and PET/MRI
Philipp Heusch et al.
EUROPEAN JOURNAL OF RADIOLOGY (2013)
Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large B-cell lymphoma - a whole-body MRI and diffusion-weighted imaging study
Xingchen Wu et al.
NMR IN BIOMEDICINE (2013)
Whole-body diffusion-weighted magnetic resonance imaging at 3 Tesla for early assessment of treatment response in non-Hodgkin lymphoma: a pilot study
Katja De Paepe et al.
CANCER IMAGING (2013)
The clinical application of whole-body diffusion-weighted imaging in the early assessment of chemotherapeutic effects in lymphoma: the initial experience
Yunbin Chen et al.
MAGNETIC RESONANCE IMAGING (2012)
Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients
Goran Abdulqadhr et al.
ACTA RADIOLOGICA (2011)
Whole-Body Diffusion-Weighted Imaging: The Added Value to Whole-Body MRI at Initial Diagnosis of Lymphoma
Jing Gu et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)
Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria
Pierre-Yves Le Roux et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma - a pilot study: comparison with 2-deoxy-2-fluoro-D-glucose-positron emission tomography/computed tomography
Xingchen Wu et al.
NMR IN BIOMEDICINE (2011)
Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma
Chieh Lin et al.
EUROPEAN RADIOLOGY (2010)
Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation
Andrea Gallamini et al.
LEUKEMIA & LYMPHOMA (2009)
Report on the First International Workshop on interim-PET scan in lymphoma
Michel Meignan et al.
LEUKEMIA & LYMPHOMA (2009)
Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology
Thomas C. Kwee et al.
EUROPEAN RADIOLOGY (2008)
Early interim 2-[18F]Fluoro-2-Deoxy-D-Glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma:: A report from a joint Italian-Danish study
Andrea Gallamini et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
2-[Fluorine-18]-fluoro-2-deOXY-D-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MR1 for detection of malignant lesions: initial experience
Tsuyoshi Komori et al.
ANNALS OF NUCLEAR MEDICINE (2007)
Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in lymphoma
Malik E. Juweid et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Body diffusion-weighted MR imaging using high b-value for malignant tumor screening: Usefulness and necessity of referring to T2-weighted images and creating fusion images
Yoshito Tsushima et al.
ACADEMIC RADIOLOGY (2007)
Total-body MR-imaging in oncology
Juergen F. Schaefer et al.
EUROPEAN RADIOLOGY (2006)
FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma
NG Mikhaeel et al.
ANNALS OF ONCOLOGY (2005)
Response assessment of aggressive non-Hodgkin's lymphoma by integrated international workshop criteria and fluorine-18-fluorodeoxyglucose positron emission tomography
ME Juweid et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma
H Schöder et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Clinical applications of PET in oncology
EM Rohren et al.
RADIOLOGY (2004)
Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma
Einat Even-Sapir et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL)
G Jerusalem et al.
ANNALS OF ONCOLOGY (2001)
Share Paper
